ALGS vs TFX · rev $3.6M vs P/E 2083, rev $3.05B
Aligos Therapeutics Inc (ALGS) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
ALGS currently screens at market cap $44.1M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the ALGS and TFX stock pages for the full models.
Not investment advice.